Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Coronary Angioplasty in Chronic Total Occlusions (CTO): Are There Sex Differences?

Studies and registries assessing sex differences in chronic total occlusions (CTO) are limited and women are under-represented, accounting for only 14%-21% of included patients. Even though success rate is comparable between sexes, several studies have shown higher complications rate among women.  

Angioplastia coronaria en oclusiones totales crónicas (CTO): ¿Hay diferencias entre ambos sexos?

The aim of this study was to identify sex related baseline and procedural differences, as well as intervention success and inhospital clinical outcomes after CTO PCI. It was based on a prospective, multicenter European study on CTO.

Primary end point was procedural success rate between cohorts (men vs women) defined as TIMI=3 and residual stenosis lower than 20%. Secondary end points were inhospital major adverse cardiovascular and cerebrovascular events (MACCEs) and procedural complications. 

The study looked at 35449 patients enrolled in the registry, 15.2% of which were women. As regards baseline characteristics, women were older (P<0.001), has more hypertension (P<0.001) and diabetes (P<0.001). Women more often presented angina, and FC III or IV (P<0.001). However, showed lower prevalence of prior AMI, prior PCI or CABG and lower three- vessel disease vs men. The right coronary artery was most frequently affected with no difference between sexes.  Nevertheless, women presented lower J-CTO score (2.02 ± 1.26 vs. 2.23 ± 1.27, p < 0.001). 

Read also: Abbreviated Antiaggregant Treatment in High Bleeding Risk Patients from the MASTER-DAPT (15-Month Followup).

The anterograde strategy was the preferred one for women (P=0.002), while the retrograde was more used in men (P<0.001). The amount of contrast used (P<0.001), fluoroscopy time (P< 0.001) and total procedural time (P<0.001) were significantly lower in women vs. men. 

As regards primary end point, CTO recanalization rate was higher in women (87.3% vs. 86.3%, p = 0.046). When it came to the secondary end point, there were no differences in terms of inhospital MACCEs, but complications such as coronary perforation (3.7% vs.2.8%, p < 0.001), vascular complications (1.0% vs. 0.6%, p < 0.001) and major bleeding (0.4% vs. 0.2%, p < 0.001) were more frequent in women. 

Conclusion

In this multicenter European registry on CTO, women represented less than 15.2% of the cohort and there was a high CTO recanalization rate. While there were no differences between sexes when it came to inhospital MACCEs, procedural complications were more frequent in women vs. men. There were no differences as regards procedural success predictors related to coronary anatomy or CTO characteristics.  

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.

Reference: Alexandre Avran MD et al Catheter Cardiovasc Interv. 2023;101:918–931.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...